Cargando…
599. LiaF is an Activator of the LiaR-Mediated Response Against Daptomycin and Antimicrobial Peptides in Multidrug-Resistant Enterococcus faecalis (Efs)
BACKGROUND: Daptomycin (DAP) is a key first-line agent for the treatment of vancomycin-resistant enterococcal infections. Resistance to DAP in enterococci is regulated by the liaFSR three-component regulatory system that consists of a histidine kinase sensor (LiaS), a response regulator (LiaR) and a...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810921/ http://dx.doi.org/10.1093/ofid/ofz360.668 |
_version_ | 1783462353144119296 |
---|---|
author | Ortiz-Velez, Laura C Rincon, Sandra L Degani, Jesse Shamoo, Yousif Tran, Truc T Arias, Cesar A Panesso, Diana |
author_facet | Ortiz-Velez, Laura C Rincon, Sandra L Degani, Jesse Shamoo, Yousif Tran, Truc T Arias, Cesar A Panesso, Diana |
author_sort | Ortiz-Velez, Laura C |
collection | PubMed |
description | BACKGROUND: Daptomycin (DAP) is a key first-line agent for the treatment of vancomycin-resistant enterococcal infections. Resistance to DAP in enterococci is regulated by the liaFSR three-component regulatory system that consists of a histidine kinase sensor (LiaS), a response regulator (LiaR) and a transmembrane protein of unknown function (LiaF). Previous studies indicate that deletion of isoleucine in position 177 of LiaF results in DAP tolerance and is sufficient to change membrane architecture. Here, we dissect the role of LiaF in DAP resistance METHODS: We generated three liaF mutants in OG1RF, a DAP-susceptible laboratory strain of Efs (DAP MIC = 2 µg/mL): (i) a non-polar, C-terminal truncation of liaF (OG1RF(liaF∆152)), (ii) a null liaF mutant with a premature stop-codon (OG1RF(liaF*11)), and (iii) an isoleucine deletion at position 177 (OG1RF(liaF177)). We determined DAP MIC by Etest and characterized the localization of anionic phospholipids microdomains using 10-nonyl-acridine-orange (NAO). The expression of the liaXYZ (the main target of LiaR) and liaFSR clusters were evaluated by qRT-PCR and relative expression ratios (Log(2) fold change) were calculated by normalizing to gyrB expression. We assessed activation of LiaFSR by evaluating surface exposure of LiaX by ELISA. We used the bacterial adenylate cyclase two-hybrid system (BACTH) to evaluate the protein-protein interaction between LiaF and LiaS. RESULTS: Full deletion of liaF or the C-terminal truncation of LiaF did not have any effect on DAP MICs, membrane architecture or a significant increase in LiaX surface exposure compared with parental strain OG1RF. In contrast, deletion of the codon encoding isoleucine in position 177 of LiaF caused a major increase (8-fold) in LiaX exposure and redistribution of anionic phospholipid microdomains away from the septum without changes in the actual DAP MIC. Transcriptional analyses indicated upregulation (>2 log(2)-fold) in the liaXYZ gene cluster indicating activation of the stress response. We also observed a positive interaction between LiaF and LiaS. CONCLUSION: LiaF is likely a key activator of the LiaFSR stress response and the critical regulatory domain appears to be located in a stretch of four isoleucines toward the C-terminal of the protein. DISCLOSURES: All authors: No reported disclosures. |
format | Online Article Text |
id | pubmed-6810921 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-68109212019-10-28 599. LiaF is an Activator of the LiaR-Mediated Response Against Daptomycin and Antimicrobial Peptides in Multidrug-Resistant Enterococcus faecalis (Efs) Ortiz-Velez, Laura C Rincon, Sandra L Degani, Jesse Shamoo, Yousif Tran, Truc T Arias, Cesar A Panesso, Diana Open Forum Infect Dis Abstracts BACKGROUND: Daptomycin (DAP) is a key first-line agent for the treatment of vancomycin-resistant enterococcal infections. Resistance to DAP in enterococci is regulated by the liaFSR three-component regulatory system that consists of a histidine kinase sensor (LiaS), a response regulator (LiaR) and a transmembrane protein of unknown function (LiaF). Previous studies indicate that deletion of isoleucine in position 177 of LiaF results in DAP tolerance and is sufficient to change membrane architecture. Here, we dissect the role of LiaF in DAP resistance METHODS: We generated three liaF mutants in OG1RF, a DAP-susceptible laboratory strain of Efs (DAP MIC = 2 µg/mL): (i) a non-polar, C-terminal truncation of liaF (OG1RF(liaF∆152)), (ii) a null liaF mutant with a premature stop-codon (OG1RF(liaF*11)), and (iii) an isoleucine deletion at position 177 (OG1RF(liaF177)). We determined DAP MIC by Etest and characterized the localization of anionic phospholipids microdomains using 10-nonyl-acridine-orange (NAO). The expression of the liaXYZ (the main target of LiaR) and liaFSR clusters were evaluated by qRT-PCR and relative expression ratios (Log(2) fold change) were calculated by normalizing to gyrB expression. We assessed activation of LiaFSR by evaluating surface exposure of LiaX by ELISA. We used the bacterial adenylate cyclase two-hybrid system (BACTH) to evaluate the protein-protein interaction between LiaF and LiaS. RESULTS: Full deletion of liaF or the C-terminal truncation of LiaF did not have any effect on DAP MICs, membrane architecture or a significant increase in LiaX surface exposure compared with parental strain OG1RF. In contrast, deletion of the codon encoding isoleucine in position 177 of LiaF caused a major increase (8-fold) in LiaX exposure and redistribution of anionic phospholipid microdomains away from the septum without changes in the actual DAP MIC. Transcriptional analyses indicated upregulation (>2 log(2)-fold) in the liaXYZ gene cluster indicating activation of the stress response. We also observed a positive interaction between LiaF and LiaS. CONCLUSION: LiaF is likely a key activator of the LiaFSR stress response and the critical regulatory domain appears to be located in a stretch of four isoleucines toward the C-terminal of the protein. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6810921/ http://dx.doi.org/10.1093/ofid/ofz360.668 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Ortiz-Velez, Laura C Rincon, Sandra L Degani, Jesse Shamoo, Yousif Tran, Truc T Arias, Cesar A Panesso, Diana 599. LiaF is an Activator of the LiaR-Mediated Response Against Daptomycin and Antimicrobial Peptides in Multidrug-Resistant Enterococcus faecalis (Efs) |
title | 599. LiaF is an Activator of the LiaR-Mediated Response Against Daptomycin and Antimicrobial Peptides in Multidrug-Resistant Enterococcus faecalis (Efs) |
title_full | 599. LiaF is an Activator of the LiaR-Mediated Response Against Daptomycin and Antimicrobial Peptides in Multidrug-Resistant Enterococcus faecalis (Efs) |
title_fullStr | 599. LiaF is an Activator of the LiaR-Mediated Response Against Daptomycin and Antimicrobial Peptides in Multidrug-Resistant Enterococcus faecalis (Efs) |
title_full_unstemmed | 599. LiaF is an Activator of the LiaR-Mediated Response Against Daptomycin and Antimicrobial Peptides in Multidrug-Resistant Enterococcus faecalis (Efs) |
title_short | 599. LiaF is an Activator of the LiaR-Mediated Response Against Daptomycin and Antimicrobial Peptides in Multidrug-Resistant Enterococcus faecalis (Efs) |
title_sort | 599. liaf is an activator of the liar-mediated response against daptomycin and antimicrobial peptides in multidrug-resistant enterococcus faecalis (efs) |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810921/ http://dx.doi.org/10.1093/ofid/ofz360.668 |
work_keys_str_mv | AT ortizvelezlaurac 599liafisanactivatoroftheliarmediatedresponseagainstdaptomycinandantimicrobialpeptidesinmultidrugresistantenterococcusfaecalisefs AT rinconsandral 599liafisanactivatoroftheliarmediatedresponseagainstdaptomycinandantimicrobialpeptidesinmultidrugresistantenterococcusfaecalisefs AT deganijesse 599liafisanactivatoroftheliarmediatedresponseagainstdaptomycinandantimicrobialpeptidesinmultidrugresistantenterococcusfaecalisefs AT shamooyousif 599liafisanactivatoroftheliarmediatedresponseagainstdaptomycinandantimicrobialpeptidesinmultidrugresistantenterococcusfaecalisefs AT trantruct 599liafisanactivatoroftheliarmediatedresponseagainstdaptomycinandantimicrobialpeptidesinmultidrugresistantenterococcusfaecalisefs AT ariascesara 599liafisanactivatoroftheliarmediatedresponseagainstdaptomycinandantimicrobialpeptidesinmultidrugresistantenterococcusfaecalisefs AT panessodiana 599liafisanactivatoroftheliarmediatedresponseagainstdaptomycinandantimicrobialpeptidesinmultidrugresistantenterococcusfaecalisefs |